Omega Healthcare Investors (NYSE:OHI) Price Target Raised to $46.00

Omega Healthcare Investors (NYSE:OHI) had its price target hoisted by Mizuho from $45.00 to $46.00 in a research note issued to investors on Monday morning, Marketbeat Ratings reports. Mizuho currently has a neutral rating on the real estate investment trust’s stock.

Several other research firms have also commented on OHI. Barclays began coverage on shares of Omega Healthcare Investors in a research note on Tuesday, July 7th. They issued an “underweight” rating and a $51.00 price objective for the company. Citigroup boosted their target price on Omega Healthcare Investors from $52.00 to $58.00 and gave the stock a “buy” rating in a research note on Tuesday, August 4th. Weiss Ratings raised Omega Healthcare Investors from a “buy (b)” rating to a “buy (b+)” rating in a report on Tuesday, June 30th. Royal Bank Of Canada increased their price target on Omega Healthcare Investors from $47.00 to $48.00 and gave the company a “sector perform” rating in a research report on Monday, May 4th. Finally, Raymond James Financial began coverage on shares of Omega Healthcare Investors in a research report on Tuesday, June 16th. They set an “outperform” rating and a $50.00 target price for the company. Six analysts have rated the stock with a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. According to data from MarketBeat, Omega Healthcare Investors has a consensus rating of “Hold” and a consensus target price of $49.50.

Omega Healthcare Investors Trading Up 0.5%

Shares of NYSE:OHI opened at $47.02 on Monday. The stock has a market cap of $14.25 billion, a PE ratio of 16.79, a price-to-earnings-growth ratio of 1.89 and a beta of 0.58. The stock’s fifty day simple moving average is $48.35 and its two-hundred day simple moving average is $47.10. Omega Healthcare Investors has a 1-year low of $39.26 and a 1-year high of $52.39.

Omega Healthcare Investors (NYSE:OHI) last posted its earnings results on Wednesday, July 29th. The real estate investment trust reported $1.19 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.51 by $0.68. Omega Healthcare Investors had a net margin of 66.96% and a return on equity of 15.76%. The firm had revenue of $328.25 million during the quarter, compared to analyst estimates of $266.97 million. During the same quarter in the prior year, the business posted $0.77 EPS. The business’s revenue was up 16.2% compared to the same quarter last year. Omega Healthcare Investors has set its FY 2026 guidance at 3.220-3.260 EPS. On average, sell-side analysts forecast that Omega Healthcare Investors will post 3.12 earnings per share for the current fiscal year.

Omega Healthcare Investors Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, August 14th. Stockholders of record on Monday, August 3rd were paid a dividend of $0.68 per share. This represents a $2.72 annualized dividend and a dividend yield of 5.8%. The ex-dividend date was Monday, August 3rd. This is a positive change from Omega Healthcare Investors’s previous quarterly dividend of $0.67. Omega Healthcare Investors’s dividend payout ratio is currently 97.14%.

Institutional Investors Weigh In On Omega Healthcare Investors

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OHI. BlackRock Inc. bought a new position in Omega Healthcare Investors during the second quarter worth about $1,838,155,000. California State Teachers Retirement System raised its position in shares of Omega Healthcare Investors by 4,652.4% in the second quarter. California State Teachers Retirement System now owns 16,435,725 shares of the real estate investment trust’s stock valued at $783,655,000 after purchasing an additional 16,089,882 shares during the period. State Street Corp lifted its stake in shares of Omega Healthcare Investors by 4.8% during the 2nd quarter. State Street Corp now owns 14,591,873 shares of the real estate investment trust’s stock valued at $534,792,000 after buying an additional 671,473 shares in the last quarter. Geode Capital Management LLC lifted its stake in shares of Omega Healthcare Investors by 9.4% during the 4th quarter. Geode Capital Management LLC now owns 8,515,924 shares of the real estate investment trust’s stock valued at $377,648,000 after buying an additional 734,774 shares in the last quarter. Finally, Bank of New York Mellon Corp bought a new position in Omega Healthcare Investors in the 2nd quarter worth approximately $275,230,000. 65.25% of the stock is currently owned by institutional investors.

About Omega Healthcare Investors

Omega Healthcare Investors, Inc is a real estate investment trust (REIT) that specializes in the ownership and management of healthcare-related facilities. The company’s core business involves acquiring and leasing long-term care properties, including skilled nursing facilities and assisted living communities, under net lease agreements. Its portfolio is designed to provide stable, inflation-protected cash flows from operators responsible for day-to-day property management.

Founded in 1992 and headquartered in Hunt Valley, Maryland, Omega Healthcare Investors has grown its holdings to encompass hundreds of facilities across the United States, with a smaller presence in select international markets.